Security key
80880W205
Scilex Holding Co - Common Stock, $0.0001 par value per share (SCLX)
CUSIP: 80880W205
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 1,119,739
- Total 13F value
- $13,661,197
- Share change
- +379,068
- SEC-reported price per share
- $12.20
- Number of holders
- 78
- Value change
- +$3,630,948
- Number of buys
- 21
- Number of sells
- 26
- Shares outstanding
- 263,415,596
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
78
Top holders
10
SCLX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Scilex Holding Co SEC filings
Scilex Holding Co company facts
Scilex Holding Co 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 80880W205
Recent filing periods:
Ownership snapshot
Top reported holders of SCLX - Scilex Holding Co - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SCLX Stock Acquisition JV...
Disclosed value leader
Scilex Holding Co
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
3/4/5
13F
Lead comparable stake: 21%
13D/G row: SCLX Stock Acquisition JV LLC
Showing 1-6 of 15 holder rows.
Quick read
SCLX Stock Acquisition JV LLC leads the comparable SEC ownership view at 21%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SCLX Stock Acquisition JV LLC's linked filing trail.
Comparable ownership
Top 5
SCLX Stock Acquisition JV LLC
21%
ORAMED PHARMACEUTICALS INC.
4.9%
Scilex Holding Co
93%
VANGUARD GROUP INC
0.11%
BlackRock, Inc.
0.04%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SCLX Stock Acquisition JV LLC |
13D/G
|
21%
|
$16,117,386
80,586,928 shares
|
-$805,874 | 21 Jan 2025 |
| ORAMED PHARMACEUTICALS INC. |
13D/G
|
4.9%
|
$5,438,249
437,510 shares
|
-$4,921,820 | 31 Dec 2025 |
| Scilex Holding Co |
3/4/5
10%+ Owner
|
93%
|
$131,853,773
244,445,260 shares
|
-$10,001,498 | 26 Dec 2025 |
| VANGUARD GROUP INC |
13F
Company
|
0.11%
|
$5,558,104
282,424 shares
|
— | 30 Sep 2025 |
| BlackRock, Inc. |
13F
Company
|
0.04%
|
$1,936,157
98,382 shares
|
— | 30 Sep 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.03%
|
$1,459,347
74,139 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
78
Shares
1,119,739
Rows available
78
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
79
Q4 2025 holders
78
Holder diff
-1
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend